Statera Biopharma Inc (STAB) – “Changing the way people think about immunotherapy.” This company is restoring immune health through leveraging complex pleiotropic beneficial effects. They believe that beneficial safe drugs act as natural analogs in a paracrine fashion, as well as a trans-activator, to resolve disease and elicit homeostasis
The company has recently entered into an agreement with Immune Therapeutics Inc. to sell rights to naltrexone and met-enkephalin. Under the expected terms, Statera will receive an initial upfront payment plus 5% of the issued and outstanding stock of Immune Therapeutics. The company will also receive payments for revenue-based milestones, new indications, and royalties, in exchange for its rights to any product containing low-dose naltrexone. This penny stock has been near $7 in the past and maybe setting itself up to achieve even higher in the future.
Visit www.staterabiopharma.com to learn more.
www.getgreenstocks.com / www.thewallstreetspy.com / www.smartsmallcaps.com